Julius Clinical’s Post

View organization page for Julius Clinical, graphic

12,822 followers

We’re excited to announce, that Weiwei X., a master's student of epidemiology at Universiteit Utrecht, abstract titled "𝗛𝗲𝗽𝗮𝘁𝗶𝗰 𝗳𝗶𝗯𝗿𝗼𝘀𝗶𝘀 𝗱𝗲𝘁𝗲𝗿𝗺𝗶𝗻𝗲𝘀 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗿𝗶𝘀𝗸 𝗶𝗻 𝗧𝟮𝗗𝗠 𝗶𝗻𝗱𝗲𝗽𝗲𝗻𝗱𝗲𝗻𝘁 𝗳𝗿𝗼𝗺 𝗼𝘁𝗵𝗲𝗿 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗿𝗶𝘀𝗸 𝗳𝗮𝗰𝘁𝗼𝗿𝘀: 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗔𝗹𝗲𝗖𝗮𝗿𝗱𝗶𝗼 𝗧𝗿𝗶𝗮𝗹" has been selected for an oral presentation at the upcoming 𝗔𝗻𝗻𝘂𝗮𝗹 𝗗𝘂𝘁𝗰𝗵 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 (𝗔𝗗𝗗𝗥𝗠) 𝟮𝟬𝟮𝟰. The abstract, which stems from the AleCardio study from Julius Clinical, represents a significant contribution to the field of diabetes research. Weiwei XU is honored to share these findings at the ADDRM, which will take place from November 14th-15th in Wageningen. More details about the meeting can be found here: https://www.addrm.online/

To view or add a comment, sign in

Explore topics